Dec 04, 2025 8:30am EST Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop
Sep 23, 2025 8:30am EDT Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity
Aug 12, 2025 6:30am EDT Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress
Aug 11, 2025 8:30am EDT Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study
